Prevalence

Radiofrequency Ablation Device Market Global Forecast Report and Company Analysis 2024-2032 Featuring Boston Scientific, Abbott, AtriCure, Medtronic, Stryker, Smith & Nephew, Conmed and Hologic - ResearchAndMarkets.com

Retrieved on: 
Friday, September 13, 2024

The "Radiofrequency Ablation Device Market Global Forecast Report by Product Application End Users Countries and Company Analysis, 2024-2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Radiofrequency Ablation Device Market Global Forecast Report by Product Application End Users Countries and Company Analysis, 2024-2032" report has been added to ResearchAndMarkets.com's offering.
  • Global Radiofrequency Ablation Device market will grow from US$ 9.98 trillion by 2032 up from US$ 4.06 billion in 2023 with CAGR of 10.51 % from 2024 to 2032.
  • It is widely used in operations such as endoscopic surgery since it enables specific destruction of pathological tissue without affecting the healthy tissue.
  • The Asia Radiofrequency Ablation Device Market is on the rise on the back of the following factors.

Endometriosis pain leads to missed school and work in two-thirds of women with the condition, new study finds

Retrieved on: 
Friday, September 13, 2024

Our study also found that Black and Hispanic women were less likely to be diagnosed with endometriosis compared with white women.

Key Points: 
  • Our study also found that Black and Hispanic women were less likely to be diagnosed with endometriosis compared with white women.
  • Interestingly, women who identified as part of the LGBTQ community had a higher likelihood of receiving an endometriosis diagnosis than heterosexual women.
  • The survey data use adjusted weights to account for the racial composition of U.S. society, meaning our sample of 17,619 women represents 51,981,323 women of the U.S. population.

Why it matters

  • These abnormally located lesions respond to hormonal changes during the menstrual cycle, causing pain when stimulated by the hormones that regulate the menstrual cycle.
  • More than 67% reported missed work or school, or having been unable to perform daily activities, due to pain associated with endometriosis.
  • Black women had 63% lower odds of getting an endometriosis diagnosis, and Hispanic women had 55% lower odds compared with non-Hispanic white women.
  • We found that non-heterosexual lesbian, gay, bisexual, transgender and queer women had 54% higher odds of receiving an endometriosis diagnosis compared with straight women.

What other research is being done

Dermal Fillers Market Insights Report 2024-2029: Increasing Trend of Customization and Personalization, Growing Desire for Long-lasting Injectables, Rising Popularity of Dermal Fillers among Men - ResearchAndMarkets.com

Retrieved on: 
Friday, September 13, 2024

There is growth in the market for dermal fillers as new products and treatments enter the market.

Key Points: 
  • There is growth in the market for dermal fillers as new products and treatments enter the market.
  • The APAC region shows the highest growth in the global dermal fillers market during the forecast period.
  • The APAC dermal fillers market is expected to experience a rapid increase in demand and market size in the coming years.
  • Growing urbanization, rising disposable income, and increasing acceptance of such treatments among men and women are also expected to contribute to the growing market.

BostonGene Announces Acceptance of Three Abstracts for Presentation at ESMO Congress 2024

Retrieved on: 
Friday, September 13, 2024

BostonGene a leading provider of artificial intelligence (AI)-driven molecular and immune profiling solutions, announced today that it will present three abstracts at ESMO Congress 2024 .

Key Points: 
  • BostonGene a leading provider of artificial intelligence (AI)-driven molecular and immune profiling solutions, announced today that it will present three abstracts at ESMO Congress 2024 .
  • The Congress aims to highlight potentially practice-changing data and foster multidisciplinary discussions to enhance treatment options for cancer patients.
  • The ESMO Congress 2024 will take place from September 13 to 17 in Barcelona, Spain, at the Fira Barcelona Gran Via.
  • For more information, please visit the ESMO Congress 2024 website .

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

Retrieved on: 
Friday, September 13, 2024

The volume of prescriptions and the budget allocated to them by public health insurance schemes are exploding, as are the profits of the companies that manufacture them.

Key Points: 
  • The volume of prescriptions and the budget allocated to them by public health insurance schemes are exploding, as are the profits of the companies that manufacture them.
  • Part of the popularity of these drugs owes to social networks, but these are not always the best source for health information.

The best of both worlds

  • When studies were carried out to assess their safety and efficacy, it was discovered that these drugs also led to weight loss.
  • The mode of action of these drugs on blood sugar regulation is clear: they simulate incretin hormones which, in turn, increase insulin secretion.

A new era

  • The physical and mental suffering these cause and the costs associated with treating them are both considerable.
  • So the arrival of new weapons in the therapeutic arsenal is a source of hope.
  • Support services of this kind do exist, but only in large university hospital centres to which many people do not have access.
  • Nor do many people have easy access to healthy and varied food options, sports facilities or social and psychological support.
  • Nor should we underestimate the challenge of adapting physically and psychologically to a body transformation of this scale.

What lessons can we learn?

Obesity Action Coalition (OAC) Responds to New CDC Obesity Maps, Calls for Expanded Access to Care

Retrieved on: 
Thursday, September 12, 2024

"This understanding is fundamental to developing effective strategies for obesity prevention, treatment and support."

Key Points: 
  • "This understanding is fundamental to developing effective strategies for obesity prevention, treatment and support."
  • "We need to double down on our efforts to ensure that everyone affected by obesity has access to the care and support they need.
  • This includes advocating for policies that improve access to obesity treatments, educating healthcare providers about obesity management and working to reduce stigma."
  • Additionally, take action by signing the OAC's national petition for access and affordability changes in obesity care policies.

NFL Alumni & Giants Great Victor Cruz Team Up To Celebrate Hispanic Heritage Month

Retrieved on: 
Thursday, September 12, 2024

From September 15 through October 15, New York Giants football great and Super Bowl Champion Victor Cruz, who is of Puerto Rican decent, will serve as program Ambassador.

Key Points: 
  • From September 15 through October 15, New York Giants football great and Super Bowl Champion Victor Cruz, who is of Puerto Rican decent, will serve as program Ambassador.
  • Locally, the New York Giants organization is lending a ‘Giant Blue’ hand in support of Hispanic Heritage Month by running themed videos in-stadium, sharing content during weekly programming and driving social media activity.
  • “Many in the Hispanic community may not be aware that living with a disease like obesity can impact the rest of your health,” says Giants alum Victor Cruz.
  • We’re honored to partake in Hispanic Heritage Month, a time of great celebration, love and family.

North Western Toronto Ontario Health Team Celebrates the Grand Opening of Innovative Community Hub

Retrieved on: 
Thursday, September 12, 2024

TORONTO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The North Western Toronto (NWT) Ontario Health Team (OHT) has officially launched The HUB@2115 at Humber River Health’s Finch Campus.

Key Points: 
  • TORONTO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The North Western Toronto (NWT) Ontario Health Team (OHT) has officially launched The HUB@2115 at Humber River Health’s Finch Campus.
  • The grand opening represents a significant leap forward in delivering comprehensive, equitable, and accessible care to the residents of North Western Toronto.
  • The HUB@2115 is designed to overcome historic barriers by providing a range of services that address both health and social challenges.
  • "We know the population of North Western Toronto faces many barriers to health and social care," says Cheryl Prescod, Executive Director of Black Creek Community Health Centre, and Co-Chair of the Senior Executive Committee for the NWT OHT.

Swift Medical Selected for Consortium to Advance Pressure Injury Prevention with AI

Retrieved on: 
Thursday, September 12, 2024

Award-winning Swift Medical brings deep AI and machine learning expertise in healthcare to partner with the PressureSmart consortium.

Key Points: 
  • Award-winning Swift Medical brings deep AI and machine learning expertise in healthcare to partner with the PressureSmart consortium.
  • This approach allows healthcare systems or payers to select elements of the PressureSmart solution that will address prevention, management or post-discharge monitoring of PIs based on their specific needs.
  • Swift Skin & Wound has demonstrated its ability to reduce PI prevalence, days to heal and associated regulatory citations1.
  • Data collected by Swift will be integrated into the PressureSmart solution to support PI prevention and management capabilities.

Rapid Acting Insulin Market Research Report 2024: Forecast by Product, Indication, Distribution Channel, Countries and Company Analysis to 2032 - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 12, 2024

The "Rapid Acting Insulin Market Report, Forecast by Product, Indication, Distribution Channel, Countries and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Rapid Acting Insulin Market Report, Forecast by Product, Indication, Distribution Channel, Countries and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.
  • The market is mainly driven by growth rate of diabetes and the rise in investment in research and development for human recombinant insulin.
  • Globally, rapid acting insulin has turned into an essential part of controlling both type 1 and type 2 diabetes.
  • Technological advancements in insulin delivery systems:
    Enhancements of insulin delivery systems are prospectively the major growth contributors to the global demand of rapid-acting insulin.